Funding for this research was provided by:
Novartis Pharma AG
Novartis Finland Oy
Received: 7 July 2020
Accepted: 17 September 2020
First Online: 29 September 2020
Ethics approval and consent to participate
: Participants were recruited by means of existing online panels (GfK Health) and support organizations for people with migraine. Participants’ consent was obtained prior to participation in the survey. Survey data were handled confidentially, and anonymity of respondents was maintained throughout the study. As such, and due to its research format, this study was exempted from ethics committee review.
: Not applicable.
: SR is employed by Novartis; MK was employed by Novartis and is currently employed by Orion Coorporation; ST, JV and SMH are employed by Medaffcon. MLS, MS and MSS do not have competing interests.